Sign our parliament petition https://bit.ly/signtosavelives Ovarian Cancer Women need your help This Ovarian Cancer Awareness Month Cure Our Ovarian Cancer …
Coping with cancer at Christmas
It’s November and already that time of year again when the Christmas adverts appear on TV and the shops are …
Binimetinib in low-grade serous carcinoma
A phase II study of Selumetinib, an oral small-molecule inhibitor of MEK1/2, has shown promising results in patients with recurrent …
Giving CuresDay on Giving Tuesday
Cure Our Ovarian Cancer is Celebrating GivingTuesday in New Zealand with #GivingCuresDay joining millions around the world participating in the …
Advanced ovarian cancer survival rates not improving
The five-year survival rates for Christchurch women with advanced ovarian cancer haven’t improved in 10 years, according to a study …
Study Shows Trametinib Improves Outcomes for Women with Low-Grade Serous Carcinoma of the Ovary/Peritoneum on NRG Oncology Trial
Results from GOG 0281, a randomised phase II/III clinical trial, were presented by Dr Gershenson on Sunday at the European …
September is Gynaecological Cancer Awareness Month
Gynaecological cancers account for 10% of all cancer diagnoses in New Zealand and ovarian cancer accounts for the most fatalities …
Low-grade serous research at The University of Otago
Dr Kenny Chitcholtan is a senior research fellow at the Department of Obstetrics and Gynaecology, The University of Otago, Christchurch, …
Low-grade serous carcinoma research grant
Donations through Cure Our Ovarian Cancer have enabled its charity partner Graci to fund a research project to study low …
World Ovarian Cancer Day
What is World Ovarian Cancer Day May 8th is World Ovarian Cancer Day – an initiative of the World Ovarian …